Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)
Simonneau Gérald, D’Armini Andrea M., Ghofrani Hossein-Ardeschir, Grimminger Friedrich, Hoeper Marius M., Jansa Pavel, Kim Nick H., Wang Chen, Wilkins Martin R., Fritsch Arno, Davie Neil, Colorado Pablo, Mayer Eckhard
Source: Eur Respir J 2015; 45: 1293-1302
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Simonneau Gérald, D’Armini Andrea M., Ghofrani Hossein-Ardeschir, Grimminger Friedrich, Hoeper Marius M., Jansa Pavel, Kim Nick H., Wang Chen, Wilkins Martin R., Fritsch Arno, Davie Neil, Colorado Pablo, Mayer Eckhard. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J 2015; 45: 1293-1302
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: